Skip to main content

Barclays Keeps Their Hold Rating on Humana (HUM)

Tipranks - Tipranks - Fri Feb 13, 6:26AM CST

In a report released today, Andrew Mok CFA from Barclays maintained a Hold rating on Humana, with a price target of $245.00.

Valentine's Day Sale - 70% Off

According to TipRanks, Mok CFA is an analyst with an average return of -1.5% and a 49.80% success rate. Mok CFA covers the Healthcare sector, focusing on stocks such as Brookdale Senior Living, Humana, and Acadia Healthcare.

In addition to Barclays, Humana also received a Hold from RBC Capital’s Ben Hendrix in a report issued today. However, on the same day, Guggenheim maintained a Buy rating on Humana (NYSE: HUM).

See the top stocks recommended by analysts >>

Based on Humana’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $32.65 billion and a net profit of $195 million. In comparison, last year the company earned a revenue of $29.4 billion and had a net profit of $480 million

Read More on HUM:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).